Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Xicheng District, Beijing, 100053, China.
China International Neuroscience Institute (China-INI), Beijing, 100053, China.
Transl Stroke Res. 2023 Aug;14(4):446-454. doi: 10.1007/s12975-022-01053-0. Epub 2022 Jun 27.
The relevance of impaired microvascular tissue reperfusion despite successful macrovascular angiographic reperfusion (no-reflow) in acute ischemic stroke (AIS) remains controversial. In this study, we aimed to investigate the impact of tissue optimal reperfusion (TOR) and its influencing factors. From December 1, 2020 to December 1, 2021, AIS patients with successful recanalization (modified Thrombolysis in Cerebral Infarction score [mTICI] ≥ 2b) after mechanical thrombectomy (MT) were retrospectively reviewed. Computed tomography perfusion was performed before and after MT. Successful reperfusion was assessed by TOR, defined as > 90% reduction of the Tmax > 6 s lesion volumes between baseline and early follow-up perfusion profiles. The impact of TOR on functional outcomes after successful recanalization and influencing factors for TOR were both investigated. Sixty-three patients were included, including 44 cases in the TOR group and 19 cases in the non-TOR group. The TOR group had a higher rate of favorable outcome (aOR 4.366, 95%CI 1.159-16.445, p = 0.030) and NIHSS improvement (aOR 5.089, 95%CI 1.340-19.322, p = 0.017) than the non-TOR group. Multivariable logistic regression showed baseline glucose (OR 0.648, 95%CI 0.492-0.854, p = 0.002) and mTICI 2c/3 (OR 10.984, 95%CI 2.220-54.343, p = 0.003) predicted TOR in model 1; in model 2, postoperative glucose (OR 0.468, 95%CI 0.278-0.787, p = 0.004) and mTICI 2c/3 (OR 9.436, 95%CI 1.889-47.144, p = 0.006) were predictive. TOR was strongly associated with good functional outcomes after successful recanalization of MT. Higher mTICI grade and lower perioperative glucose level may predict microvascular tissue reperfusion.
尽管急性缺血性脑卒中 (AIS) 患者的大血管血管造影再通 (无再流) 成功,但微血管组织再灌注受损的相关性仍存在争议。本研究旨在探讨组织最佳再灌注 (TOR) 及其影响因素。
回顾性分析 2020 年 12 月 1 日至 2021 年 12 月 1 日接受机械血栓切除术 (MT) 后成功再通 (改良脑梗死溶栓评分 [mTICI] ≥ 2b) 的 AIS 患者。在 MT 前后进行计算机断层灌注成像。通过 TOR 评估再灌注成功,定义为基线和早期随访灌注曲线之间 Tmax > 6s 病变体积减少> 90%。
研究成功再通后 TOR 对功能结局的影响及其影响因素。共纳入 63 例患者,其中 TOR 组 44 例,非 TOR 组 19 例。TOR 组的预后良好率(优势比 [OR] 4.366,95%置信区间 [CI] 1.159-16.445,p=0.030)和 NIHSS 改善率(OR 5.089,95%CI 1.340-19.322,p=0.017)均高于非 TOR 组。多变量逻辑回归显示,基线血糖(OR 0.648,95%CI 0.492-0.854,p=0.002)和 mTICI 2c/3(OR 10.984,95%CI 2.220-54.343,p=0.003)在模型 1 中预测 TOR;在模型 2 中,术后血糖(OR 0.468,95%CI 0.278-0.787,p=0.004)和 mTICI 2c/3(OR 9.436,95%CI 1.889-47.144,p=0.006)具有预测性。
TOR 与 MT 成功再通后良好的功能结局密切相关。较高的 mTICI 分级和较低的围手术期血糖水平可能预测微血管组织再灌注。